← Eichor
Study identifier: NCT07195422 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Japet.W+ Medical Device for Low Back Pain Management

Condition: Low Back Pain  ·  Sponsor: Japet Medical Devices

PhaseNA
Planned participants102
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The JAPET.W+ medical device is a new dynamic distraction support system. It could be considered as a new solution in the therapeutic arsenal for managing common low back pain. This study aims to assess the effectiveness of this device among the two targeted populations during daily use. Each patient will be asked to estimate the intensity of their low back pain several times during the clinical investigation. Our main hypothesis is a reduction in low back pain while wearing the device. The secondary hypothesis is a decrease in activity limitations, an increase in participation, an improvement in quality of life, and a reduction in healthcare product and medication consumption.

This description comes directly from the study's public registry record.

Talk to the study team

Mélissa Moulart, PhD  ·  +33671307712  ·  melissa.moulart@japet.eu

Always discuss trial participation with your own doctor first.

Locations (2)

CHU Clermont-FerrandClermont-Ferrand, FranceRecruiting
Hôpital de Cochin, APHPParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07195422